Drug Type Small molecule drug |
Synonyms NH-280105 |
Target |
Action inhibitors |
Mechanism Lp-PLA2 inhibitors(Lipoprotein-associated phospholipase A2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 1 | Australia | 12 Mar 2025 |





